行情

NEO

NEO

Neogenomics
NASDAQ

实时行情|Nasdaq Last Sale

32.05
-0.55
-1.69%
盘后: 32.41 +0.36 +1.12% 17:54 01/17 EST
开盘
32.88
昨收
32.60
最高
32.90
最低
31.82
成交量
81.06万
成交额
--
52周最高
33.21
52周最低
15.15
市值
33.38亿
市盈率(TTM)
1831.43
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NEO 新闻

  • 境生物登陆美股 CEO解答产品上市时间线
  • 新浪财经.1小时前
  • What!华尔街心头肉却成大空头眼中钉?
  • 新浪财经综合.2小时前
  • 法媒:今后30年 气候变暖将严重冲击社会经济
  • 参考消息.2小时前
  • 苹果新机规格曝光:支持5G 最低价不足3000
  • TechWeb.2小时前

更多

所属板块

医疗设施与服务
-0.07%
医疗保健提供商与服务
-0.27%

热门股票

名称
价格
涨跌幅

NEO 简况

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.
展开

Webull提供NeoGenomics, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。